Antibody responses to prime-boost vaccination with an HIV-1 gp145 Env protein and chimpanzee adenovirus vectors expressing HIV-1 gp140

OBJECTIVES: Over two million individuals are infected with human immunodeficiency virus type 1 (HIV-1) each year, yet an effective vaccine remains elusive. The most successful HIV-1 vaccine to date demonstrated 31% efficacy. Immune correlate analyses associated HIV-1 envelope (Env)-specific antibodi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:AIDS
Egile Nagusiak: EMMER, Kristel L., WIECZOREK, Lindsay, TUYISHIME, Steven, MOLNAR, Sebastian, POLONIS, Victoria R., ERTL, Hildegund C.J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069158/
https://ncbi.nlm.nih.gov/pubmed/27525550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001224
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak